NORATIS AG.
NUVA.XETRA | Research and experimental development on natural sciences and engineering
NORATIS AG, formerly NUVISAN Innovation Holding AG, is a Germany-based company that provides services to the pharmaceutical and biotech industries. It operates as a contract research organization (CRO) offering a range of services including drug development, clinical trials, bioanalysis, and regulat...Show More
Better Health for All
0
No specific, concrete data points or actions related to NUVA.XETRA (NORATIS AG) were found in the provided articles for any of the 'Better Health for All' KPIs.
1
The articles either focused on other companies or discussed general industry practices without specific relevance to NUVA.XETRA.
Fair Money & Economic Opportunity
0
The provided articles consistently describe NORATIS AG as a residential real estate developer, focusing on property portfolio management, sales, and financial restructuring.
1
The ethical value 'Fair Money & Economic Opportunity' and its associated KPIs are designed to assess financial institutions that offer lending, deposit, or other financial services to consumers. As NORATIS AG's core business, according to the articles, is residential real estate development,
2
it does not engage in activities directly relevant to consumer financial services, fair lending practices, or financial inclusion initiatives.
3
Therefore, all KPIs are scored as 'Not applicable' (0) because the company does not offer the types of financial products or services that these metrics evaluate.
Fair Pay & Worker Respect
0
No evidence available to assess NORATIS AG on Fair Pay & Worker Respect.
Fair Trade & Ethical Sourcing
0
NORATIS AG's business model, as described in the provided articles, involves acquiring and managing residential rental properties in Germany.
1
This operation focuses on real estate, including sales of inventory properties and rental income, and does not entail the procurement or trade of physical commodities or a supply chain that would typically require fair trade certifications, audits for child/forced labor in manufacturing, or traceability of raw materials.
2
Therefore, most KPIs related to Fair Trade & Ethical Sourcing are not applicable to NORATIS AG's evidenced operations. No specific data points for supplier diversity spend were found in the articles.
3
Honest & Fair Business
0
No evidence available to assess NORATIS AG on Honest & Fair Business.
Kind to Animals
0
No specific, concrete evidence was found in the provided articles regarding NUVA.XETRA's performance across any of the 'Kind to Animals' KPIs. The articles discuss general trends in non-animal research, funding for alternative methods, and the policies of other companies (NIH, Novo Nordisk, Charles River Laboratories), but do not provide any data points directly attributable to NUVA.XETRA.
No War, No Weapons
0
No evidence available to assess NORATIS AG on No War, No Weapons.
Planet-Friendly Business
-20
The provided articles state that no regulatory actions, violations, fines, or compliance issues were mentioned for NORATIS AG.
1
This indicates zero environmental compliance violations.
Respect for Cultures & Communities
0
No evidence available to assess NORATIS AG on Respect for Cultures & Communities.
Safe & Smart Tech
10
The company's privacy policy states that data is collected only as necessary and deleted after use, indicating industry-leading data minimization practices.
1
It also mentions user rights to withdraw consent and data deletion, which represents industry-standard user privacy controls.
2
Furthermore, the company states compliance with GDPR and § 5 DDG, which is a basic level of regulatory compliance.
3
Zero Waste & Sustainable Products
0
No specific, concrete evidence was found in the provided articles for NUVA.XETRA regarding any of the KPIs related to Zero Waste & Sustainable Products. The articles either discuss other companies (Retta Group, TFS HealthScience) or general sustainability metrics without providing data for NUVA.XETRA.